Long Term Survival on Haemodialysis in Primary Hyperoxaluria
| Autor: | R. Skinner, J.S. Tapson, Charles R.V. Tomson |
|---|---|
| Rok vydání: | 1990 |
| Předmět: |
medicine.medical_specialty
Treatment regimen business.industry Biomedical Engineering Medicine (miscellaneous) Bioengineering General Medicine Disease urologic and male genital diseases medicine.disease Primary therapy 030227 psychiatry Biomaterials Primary hyperoxaluria 03 medical and health sciences 0302 clinical medicine Internal medicine Long term survival medicine In patient 030212 general & internal medicine business Mild disease |
| Zdroj: | The International Journal of Artificial Organs. 13:412-415 |
| ISSN: | 1724-6040 0391-3988 |
| DOI: | 10.1177/039139889001300706 |
| Popis: | Results of treatment of end-stage renal failure (ESRF) in patients with primary hyperoxaluria have been generally poor, largely due to the inability of any treatment regime to match the endogenous overproduction of oxalate. The severity of the disease varies widely, as reflected by the differences in age at onset of ESRF. This variability may influence the results of treatment of ESRF in these patients. The longest reported survival on haemodialysis of a patient with primary hyperoxaluria is eight and a half years. We report a patient who survived for eleven years on haemodialysis after reaching ESRF due to primary hyperoxaluria, and suggest that this prolonged survival was due to relatively mild disease severity rather than exceptional treatment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|